Potentials of magnesium treatment in subarachnoid haemorrhage

Magnesium Research

Volumn 17, Issue 4, 2004, Pages 301-313

  Van Den Bergh, W M ^a   Dijkhuizen, R M ^b   Rinkel, G J E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Ischaemia; Magnesium; Neuroprotection; Review; Subarachnoid haemorrhage

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); GLUTAMATE RECEPTOR; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; PHOSPHOLIPID DERIVATIVE; PROTEIN DERIVATIVE;

BRADYCARDIA; BRAIN ISCHEMIA; BRAIN VASOSPASM; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CORRELATION ANALYSIS; DRUG POTENCY; EXCITOTOXICITY; HUMAN; HYPOMAGNESEMIA; HYPOTENSION; INTOXICATION; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; THROMBOCYTE AGGREGATION; TOXICITY; VASODILATATION;

ANIMALS; BRAIN ISCHEMIA; CALCIUM; HUMANS; MAGNESIUM; MIDDLE AGED; MITOCHONDRIA; RATS; SUBARACHNOID HEMORRHAGE; VASODILATION;

EID: 12744263413     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Clarke E. Apoplexy in Hippocratic writings. Bull Hist Med 1963; 37: 301.
2. Hippocrates, Leonicenus N, Laurentianus L. (trans.) Aphorismi, cum Galeni Commentariis; Praedictiones, cum Galeni Commentariis. Paris: Simon Sylvius; 1527.
3. Linn FH, Rinkel GJ, Algra A, Van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 1996; 27: 625-9.
4. Alkan T, Tureyen K, Ulutas M, Kahveci N, Goren B, Korfali E, Ozluk K. Acute and delayed vasoconstriction after subarachnoid hemorrhage: local cerebral blood flow, histopathology, and morphology in the rat basilar artery. Arch Physiol Biochem 2001; 109: 145-53.
5. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 1995; 26: 1086-91.
6. Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery 1988; 22: 654-61.
7. Jackowski A, Crockard A, Burnstock G, Russell RR, Kristek F. The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat. J Cereb Blood Flow Metab 1990; 10: 835-49.
8. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 2003; 52: 165-75.
9. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins AL, Vallabhajosyula P. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 1998; 42: 352-60.
10. Hop JW, Rinkel GJ, Algra A, Van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997; 28: 660-4.
11. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991; 11: 1025-30.
12. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996; 85: 117-24.
13. Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnes Res 1998; 11: 43-56.
14. Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004; 363: 439-45.
15. Belfort MA, Anthony J, Saade GR, Allen Jr. JC. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348: 304-11.
16. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-63.
17. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877-90.
18. Greene MF. Magnesium sulfate for preeclampsia. N Engl J Med 2003; 348: 275-6.
19. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-5.
20. Van den Bergh WM, Zuur JK, Kamerling NA, Van Asseldonk JT, Rinkel GJ, Tulleken CA, Nicolay K. Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg 2002; 97: 416-22.
21. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399: A7-14.
22. Paschen W, Doutheil J. Disturbances of the functioning of endoplasmic reticulum: a key mechanism underlying neuronal cell injury? J Cereb Blood Flow Metab 1999; 19: 1-18.
23. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 1995; 18: 58-60.
24. Sang N, Meng Z. Blockade by magnesium of sodium currents in acutely isolated hippocampal CA1 neurons of rat. Brain Res 2002; 952: 218-21.
25. Van der Hel WS, Van den Bergh WM, Nicolay K, Tulleken KA, Dijkhuizen RM. Suppression of cortical spreading depressions after magnesium treatment in the rat. Neuroreport, 1998; 9: 2179-82.
26. Lin JY, Chung SY, Lin MC, Cheng FC. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. Life Sci 2002; 71: 803-11.
27. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984; 4: 1884-91.
28. Schanne FA, Gupta RK, Stanton PK. 31P-NMR study of transient ischemia in rat hippocampal slices in vitro. Biochim Biophys Acta 1993; 1158: 257-63.
29. Altura BM, Altura BT. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc 1981; 40: 2672-9.
30. Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984; 309: 261-3.
31. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307: 462-5.
32. Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke 1995; 26: 503-13.
33. Johnson JW, Ascher P. Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels. Biophys J 1990; 57: 1085-90.
34. Katusic ZS, Shepherd JT. Endothelium-derived vasoactive factors: II. Endothelium-dependent contraction. Hypertension 1991; 18: III86-III92.
35. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke 1997; 28: 1283-8.
36. Gahm C, Holmin S, Mathiesen T. Nitric oxide synthase expression after human brain contusion. Neurosurgery 2002; 50: 1319-26.
37. Gahm C, Holmin S, Mathiesen T. Temporal profiles and cellular sources of three nitric oxide synthase isoforms in the brain after experimental contusion. Neurosurgery 2000; 46: 169-77.
38. Kumura E, Kosaka H, Shiga T, Yoshimine T, Hayakawa T. Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 1994; 14: 487-91.
39. Sehba FA, Schwartz AY, Chereshnev I, Bederson JB. Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2000; 20: 604-11.
40. Cooper CE. Nitric oxide and iron proteins. Biochim Biophys Acta 1999; 1411: 290-309.
41. Sakowitz OW, Wolfrum S, Sarrafzadeh AS, Stover JF, Dreier JP, Dendorfer A, Benndorf G, Lanksch WR, Unterberg AW. Relation of cerebral energy metabolism and extracellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2001; 21: 1067-76.
42. Kim P, Schini VB, Sundt Jr. TM, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992; 70: 248-56.
43. Sehba FA, Ding WH, Chereshnev I, Bederson JB. Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage. Stroke 1999; 30: 1955-61.
44. Pearson PJ, Evora PR, Seccombe JF, Schaff HV. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thorac Surg 1998; 65: 967-72.
45. Shechter M. The role of magnesium as antithrombotic therapy. Wien Med Wochenschr 2000; 150: 343-7.
46. Sun X, Mei Y, Tong E. Effect of magnesium on nitric-oxide synthase of neurons in cortex during early period of cerebral ischemia. J Tongji Med Univ 2000; 20: 13-5; 42.
47. Garnier Y, Middelanis J, Jensen A, Berger R. Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen-glucose deprivation: mediation by nitric oxide system. J Soc Gynecol Investig 2002; 9: 86-92.
48. Honda Y. Cellular and molecular biology of ischemic retina. Nippon Ganka Gakkai Zasshi 1996; 100: 937-55.
49. Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE. Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 1998; 32: 536-9.
50. Dickens BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992; 311: 187-91.
51. Ebel H, Gunther T. Magnesium metabolism: a review. J Clin Chem Clin Biochem 1980; 18: 257-70.
52. Trauble H, Eibl H. Electrostatic effects on lipid phase transitions: membrane structure and ionic environment. Proc Natl Acad Sci USA 1974; 71: 214-9.
53. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
54. Aoki K, Zubkov AY, Ross IB, Zhang JH. Therapeutic effect of caspase inhibitors in the prevention of apoptosis and reversal of chronic cerebral vasospasm. J Clin Neurosci 2002; 9: 672-7.
55. Nau R, Haase S, Bunkowski S, Bruck W. Neuronal apoptosis in the dentate gyrus in humans with subarachnoid hemorrhage and cerebral hypoxia. Brain Pathol 2002; 12: 329-36.
56. Zubkov AY, Tibbs RE, Clower B, Ogihara K, Aoki K, Zhang JH. Morphological changes of cerebral arteries in a canine double hemorrhage model. Neurosci Lett 2002; 326: 137-41.
57. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim. Biophys Acta 1995; 1241: 139-76.
58. Schinder AF, Olson EC, Spitzer NC, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1996; 16: 6125-33.
59. Zamzami N, Hirsch T, Dallaporta B, Petit PX, Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J Bioenerg Biomembr 1997; 29: 185-93.
60. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G. Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183: 1533-44.
61. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
62. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998; 60: 619-42.
63. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem 1998; 252: 1-15.
64. Dubinsky JM, Brustovetsky N, Pinelis V, Kristal BS, Herman C, Li X. The mitochondrial permeability transition: the brain's point of view. Biochem Soc Symp 1999; 66: 75-84.
65. Marzatico F, Gaetani P, Silvani V, Lombardi D, Sinforiani E, Baena R. Experimental isobaric subarachnoid hemorrhage: regional mitochondrial function during the acute and late phase. Surg Neurol 1990; 34: 294-300.
66. Marzatico F, Gaetani P, Baena R, Silvani V, Paoletti P, Benzi G. Bioenergetics of different brain areas after experimental subarachnoid hemorrhage in rats. Stroke 1988; 19: 378-84.
67. Baena R, Gaetani P, Silvani V, Spanu G, Marzatico F. Effect of nimodipine on mitochondrial respiration in different rat brain areas after subarachnoid haemorrhage. Acta Neurochir Suppl (Wien) 1988; 43: 177-81.
68. D'avella D, Cicciarello R, Zuccarello M, Albiero F, Romano A, Angileri FF, Salpietro FM, Tomasello F. Brain energy metabolism in the acute stage of experimental subarachnoid haemorrhage: local changes in cerebral glucose utilization. Acta Neurochir (Wien) 1996; 138: 737-43.
69. Xu M, Dai W, Deng X. Effects of magnesium sulfate on brain mitochondrial respiratory function in rats after experimental traumatic brain injury. Chin J Traumatol 2002; 5: 361-4.
70. Sharikabad MN, Ostbye KM, Brors O. Increased [Mg2+]o reduces Ca2+ influx and disruption of mitochondrial membrane potential during reoxygenation. Am J Physiol Heart Circ Physiol 2001; 281: H2113-H2123.
71. Martin H, Richert L, Berthelot A. Magnesium deficiency induces apoptosis in primary cultures of rat hepatocytes. J Nutr 2003; 133: 2505-11.
72. Turkyilmaz C, Turkyilmaz Z, Atalay Y, Soylemezoglu F, Celasun B. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. Brain Res 2002; 955: 133-7.
73. Kagstrom E, Greitz T, Hanson J, Galera R. Changes in cerebral blood flow after subarachnoid hemorrhage. Excerpta Med Int Congr Series 1966: 629-33.
74. Bergvall U, Steiner L, Forster DM. Early pattern of cerebral circulatory disturbances following subarachnoid haemorrhage. Neuroradiology 1973; 5: 24-32.
75. Bergvall U, Galera R. Time relationship between subarachnoid haemorrhage, arterial spasm, changes in cerebral circulation and posthaemorrhagic hydrocephalus. Acta Radiol Diagn (Stockh) 1969; 9: 229-37.
76. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg 1978; 48: 173-8.
77. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971-82.
78. Cook DA, Vollrath B. Free radicals and intracellular events associated with cerebrovascular spasm. Cardiovasc Res 1995; 30: 493-500.
79. Clark JF, Reilly M, Sharp FR. Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J Cereb Blood Flow Metab 2002; 22: 472-8.
80. Pluta RM, Afshar JK, Boock RJ, Oldfield EH. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg 1998; 88: 557-61.
81. Dietrich HH, Dacey Jr. RG. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000; 46: 517-30.
82. Altura BM, Zhang A, Cheng TP, Altura BT. Extracellular magnesium regulates nuclear and perinuclear free ionized calcium in cerebral vascular smooth muscle cells: possible relation to alcohol and central nervous system injury. Alcohol 2001; 23: 83-90.
83. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991; 22: 922-7.
84. Pyne GJ, Cadoux-Hudson TA, Clark JF. Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. Br J Neurosurg 2001; 15: 409-15.
85. Miura K. Changes in Mg++ concentration of CSF after subarachnoid hemorrhage and Mg++ - effects on the contractions of bovine cerebral artery. No Shinkei Geka 1988; 16: 1251-9.
86. Altura BT, Altura BM. Interactions of Mg and K on cerebral vessels - aspects in view of stroke. Review of present status and new findings. Magnesium 1984; 3: 195-211.
87. Seelig JM, Wei EP, Kontos HA, Choi SC, Becker DP. Effect of changes in magnesium ion concentration on cat cerebral arterioles. Am J Physiol 1983; 245: H22-H26.
88. Torregrosa G, Perales AJ, Salom JB, Miranda FJ, Barbera MD, Alborch E. Different effects of Mg2+ on endothelin-1- and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed. J Cardiovasc Pharmacol 1994; 23: 1004-10.
89. Van den Bergh WM, Algra A, Van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52: 276-82.
90. Frijns CJ, Rinkel GJ, Castigliego D, Van Gijn J, Sixma JJ, Fijnheer R. Endothelial cell activation after subarachnoid hemorrhage. Neurosurgery 2002; 50: 1223-9.
91. Handa Y, Kubota T, Kaneko M, Tsushida A, Kobayashi H, Kawano H. Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 1995; 132: 92-7.
92. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003; 53: 123-33.
93. Mathiesen T, Lefvert AK. Cerebrospinal fluid and blood lymphocyte subpopulations following subarachnoid haemorrhage. Br J Neurosurg 1996; 10: 89-92.
94. Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997; 87: 215-20.
95. Mathiesen T, Andersson B, Loftenius A, Von Holst H. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993; 78: 562-7.
96. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits. J Neurosurg 1997; 86: 594-602.
97. Spallone A, Acqui M, Pastore FS, Guidetti B. Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surg Neurol 1987; 27: 253-8.
98. Germano A, D'Avella D, Imperatore C, Caruso G, Tomasello F. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 2000; 142: 575-80.
99. Bertsch T, Kuehl S, Muehlhauser F, Walter S, Hodapp B, Rossol S, Schmeck J, Ragoschke A, Schutt S, Frintzinger M, Horn P, Vajkoczy P, Wellner MW, Fassbender K. Source of endothelin-1 in subarachnoid hemorrhage. Clin Chem Lab Med 2001; 39: 341-5.
100. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Wendel-Wellner M, Ragoschke A, Kuehl S, Brunner J, Schurer L, Schmiedek P, Hennerici M. Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000; 31: 2971-5.
101. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001; 70: 534-7.
102. Juvela S. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 97: 1287-93.
103. Shogi T, Oono H, Nakagawa M, Miyamoto A, Ishiguro S, Nishio A. Effects of a low extracellular magnesium concentration and endotoxin on IL-1beta and TNF-alpha release from, and mRNA levels in, isolated rat alveolar macrophages. Magnes Res 2002; 15: 147-52.
104. Kaya M, Kucuk M, Kalayci RB, Cimen V, Gurses C, Elmas I, Arican N. Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglycemia in rats. Can J Physiol Pharmacol 2001; 79: 793-8.
105. Berthon N, Laurant P, Fellmann D, Berthelot A. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol 2003; 42: 24-31.
106. Kemp PA, Gardiner SM, March JE, Rubin PC, Bennett T. Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique. Br J Pharmacol 1999; 126: 621-6.
107. Dumuis A, Pin JP, Oomagari K, Sebben M, Bockaert J. Arachidonic acid released from striatal neurons by joint stimulation of ionotropic and metabotropic quisqualate receptors. Nature 1990; 347: 182-4.
108. Dumuis A, Sebben M, Haynes L, Pin JP, Bockaert J. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 1988; 336: 68-70.
109. Juvela S, Ohman J, Servo A, Heiskanen O, Kaste M. Angiographic vasospasm and release of platelet thromboxane after subarachnoid hemorrhage. Stroke 1991; 22: 451-5.
110. Juvela S, Hillbom M, Kaste M. Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 1991; 74: 386-92.
111. Juvela S. Cerebral infarction and release of platelet thromboxane after subarachnoid hemorrhage. Neurosurgery 1990; 27: 929-35.
112. Bara M, Guiet-Bara A, Durlach J. Analysis of magnesium membraneous effects: binding and screening. Magnes Res 1988; 1: 29-34.
113. Trauble H, Eibl H. Electrostatic effects on lipid phase transitions: membrane structure and ionic environment. Proc Natl Acad Sci USA 1974; 71: 214-9.
114. Ravn HB, Vissinger H, Kristensen SD, Husted SE. Magnesium inhibits platelet activity - an in vitro study. Thromb Haemost 1996; 76: 88-93.
115. Ravn HB, Vissinger H, Kristensen SD, Wennmalm A, Thygesen K, Husted SE. Magnesium inhibits platelet activity - an infusion study in healthy volunteers. Thromb Haemost 1996; 75: 939-44.
116. Steurer G, Yang P, Rao V, Mohl W, Glogar D, Smetana R. Acute myocardial infarction, reperfusion injury, and intravenous magnesium therapy: basic concepts and clinical implications. Am Heart J 1996; 132: 478-82.
117. Serebruany VL, Herzog WR, Schlossberg ML, Gurbel PA. Bolus magnesium infusion in humans is associated with predominantly unfavourable changes in platelet aggregation and certain haemostatic factors. Pharmacol Res 1997; 36: 17-22.
118. Ravn HB, Kristensen SD, Vissinger H, Husted SE. Magnesium inhibits human platelets. Blood Coagul Fibrinolysis 1996; 7: 241-4.
119. Adams JH, Mitchell JR. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo. Thromb Haemost 1979; 42: 603-10.
120. Hughes A, Tonks RS. Magnesium, adenosine diphosphate and blood platelets. Nature 1966; 210: 106-7.
121. Bennett JS, Kolodziej MA. Disorders of platelet function. Dis Mon 1992; 38: 577-631.
122. Alborch E, Salom JB, Perales AJ, Torregrosa G, Miranda FJ, Alabadi JA, Jover T. Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries. Eur J Pharmacol 1992; 229: 83-9.
123. Perales AJ, Torregrosa G, Salom JB, Miranda FJ, Alabadi JA, Monleon J, Alborch E. In vivo and in vitro effects of magnesium sulfate in the cerebrovascular bed of the goat. Am J Obstet Gynecol 1991; 165: 1534-8.
124. Watson KV, Moldow CF, Ogburn PL, Jacob HS. Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci USA 1986; 83: 1075-8.
125. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987; 9: 379-83.
126. Warren BB, Muizelaar JP, Choi SC. Magnesium's role in cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage. In: Findlay JM, ed. Cerebral Vasospasm. 1993: 401-4.
127. Lee MS, Wu YS, Yang DY, Lee JB, Cheng FC. Significantly decreased extracellular magnesium in brains of gerbils subjected to cerebral ischemia. Clin Chim Acta 2002; 318: 121-5.
128. Kawahara E, Ikeda S, Miyahara Y, Kohno S. Role of autonomic nervous dysfunction in electrocardiographic abnormalities and cardiac injury in patients with acute subarachnoid hemorrhage. Circ J 2003; 67: 753-6.
129. Lambert G, Naredi S, Eden E, Rydenhag B, Friberg P. Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus. Brain Res Bull 2002; 58: 77-82.
130. Flink EB, Brick JE, Shane SR. Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 1981; 141: 441-3.
131. Whyte KF, Addis GJ, Whitesmith R, Reid JL. Adrenergic control of plasma magnesium in man. Clin Sci (Lond) 1987; 72: 135-8.
132. Stout AK, Li-Smerin Y, Johnson JW, Reynolds IJ. Mechanisms of glutamate-stimulated Mg2+ influx and subsequent Mg2+ efflux in rat forebrain neurones in culture. J Physiol 1996; 492(Pt 3): 641-57.
133. Jung DW, Apel L, Brierley GP. Matrix free Mg2+ changes with metabolic state in isolated heart mitochondria. Biochemistry 1990; 29: 4121-8.
134. Raftos JE, Lew VL, Flatman PW. Refinement and evaluation of a model of Mg2+ buffering in human red cells. Eur J Biochem 1999; 263: 635-45.
135. Barbour RL, Gebrewold A, Altura BT, Altura BM. Optical spectroscopy and prevention of deleterious cerebral vascular effects of ethanol by magnesium ions. Eur J Pharmacol 2002; 447: 79-86.
136. Van den Bergh WM, Algra A, Rinkel GJ. Electrocardiographic abnormalities and serum magnesium in patients with Subarachnoid Hemorrhage. Stroke 2004.
137. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96: 510-4.
138. Kirmani JF, Yahia AM, Qureshi AI, Kim SR, Bendok BR, Levy EI, et al. Pilot trial of safety and effectiveness of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. American Association of Neurological Surgeans Annual Meeting 2002.
139. Van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir (Wien) 2003; 145: 195-9.
140. Chia RY, Hughes RS, Morgan MK. Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2002; 9: 279-81.
141. Brewer RP, Parra A, Lynch J, Chilukuri V, Borel CO. Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol 2001; 13: 202-6.
142. Major Ongoing Stroke Trials. Stroke 2004; 35: E46-E57.